Figure 7.
Functional GSEA analysis of PRlncSig and model comparisons. (A) Representative KEGG pathways significantly enriched in high-risk patients. (B) Immune-related signatures significantly enriched in high-risk patients. (C) ROC analysis of the prediction of 3-year survival by PRlncSig and four other signatures.